Berlin – November 03, 2026 -- The Scientific Institute of the AOK (WIdO) expects net drug costs in Germany's statutory health insurance (GKV) to rise 2.2% to 2.8% in 2027, a sharp slowdown from the 5.5% growth projected for 2026. The brake comes from the GKV Contribution Rate Stabilisation Act (GKV-BStabG), whose additional manufacturer discount is meant to relieve payers by almost EUR 2.5 billion. WIdO says the structural drivers of spending remain untouched.

Orlando – November 03, 2026 -- Xenia Hotels & Resorts (NYSE: XHR) raised its full-year 2026 guidance after third-quarter Adjusted EBITDAre rose 26.0% to $53.2 million and Adjusted FFO per diluted share climbed 56.5% to $0.36.

Same-Property RevPAR rises 12.5% on higher occupancy and rates

Same-Property occupancy reached 70.0%, up 380 basis points year over year. Same-Property ADR increased 6.4% to $264.00, lifting Same-Property RevPAR 12.5% to $184.75. Same-Property Total RevPAR gained 12.7% to $325.71.

Bad Homburg – November 03, 2026 -- Fresenius Medical Care narrowed its 2026 operating income outlook to between flat and negative mid-single-digit growth after third-quarter reported operating income fell 19% to EUR 384 million. Reported net income dropped 42%, mainly because of EUR 108 million in one-time costs tied to the company's China strategy refinement.

MILWAUKEE – November 03, 2026 -- Regal Rexnord Corporation (NYSE: RRX) reported third-quarter sales of $1,588 million, up 6% year on year, and said it is exploring the sale of its autonomous mobile solutions business within the Automation & Motion Control (AMC) segment.

Data center sales surge 307% while GAAP result turns to a loss

Data center sales rose 307%, or 169% excluding E-Pods. Daily orders climbed 6%, and orders excluding data centers grew 13%.

SOUTH SAN FRANCISCO – November 03, 2026 -- IDEAYA Biosciences (Nasdaq: IDYA) completed its first new drug application for darovasertib plus crizotinib in metastatic uveal melanoma during the third quarter, and ended the quarter with $1.15 billion in cash, cash equivalents and marketable securities as of September 30, 2026. Cash runway guidance into 2030 is unchanged.

Stockholm – November 03, 2026 -- Svea Mining AB has appointed DNB Carnegie Investment Bank AB as liquidity provider for its shares on Spotlight Stock Market, at a cost of SEK 25,000 per month excluding VAT. DNB Carnegie took up the role on October 27, 2026, the company's first day of trading under the ticker SVEA.

Westminster, Colorado – November 03, 2026 -- Ball Corporation (NYSE: BALL) reported third-quarter 2026 comparable diluted earnings per share of $1.10, up 6.8% from $1.03 a year earlier, while U.S. GAAP results swung to a net loss of $94 million, or 36 cents per diluted share, versus earnings of $1.18 per share in 2025.

Milford, Mass. – November 03, 2026 -- Waters Corporation raised every component of its full-year 2026 guidance after third-quarter revenue of $1.767 billion beat the guidance midpoint by $14 million and adjusted EPS rose 21% to $4.10. The company lifted its total reported revenue outlook by $43 million at the midpoint.

LONDON – November 03, 2026 -- Clarivate Plc (NYSE: CLVT) closed the sale of its Life Sciences & Healthcare (LS&H) segment on October 6, 2026 for net cash proceeds of $488.4 million, and reported third-quarter organic revenue growth of 0.4% for continuing operations alongside a $80.8 million net loss driven by a goodwill impairment.

Wilmington – November 03, 2026 -- DuPont raised its full-year 2026 outlook for the second time after third-quarter net sales rose 4% to $1.9 billion, with adjusted EPS of $2.09 and transaction-adjusted free cash flow of $341 million, a 121% conversion rate.

DuPont lifts full-year adjusted EPS guidance to $7.47-$7.52

The company now expects organic growth of about 4.5%, operating EBITDA of about $1.785 billion and adjusted EPS of $7.47 to $7.52. CFO Antonella Franzen said all three metrics sit at or above the high end of previously communicated guidance.